跳至主要内容
临床试验/NCT06399146
NCT06399146招募中不适用

Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana

Hillerod Hospital, Denmark1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150
试验地点
1
主要终点
Total serum bilirubin

研究概览

简要总结

This project aims to test a novel smartphone application, Picterus, which provides a cheaper, patient-friendly, and more readily means of neonatal jaundice detection. For this purpose, the study aims to collect data from newborns with a broad range of bilirubin levels and high melanin content in a population in Botswana.

详细描述

Neonatal jaundice is a condition in newborns with elevated levels of the waste product bilirubin, also known as hyperbilirubinemia. It is primarily caused by a combination of the rapid turnover of red blood cells and the immature liver functions in the newborn. Neonatal jaundice affects approximately 60 to 80 % of newborns but is usually self-limiting and harmless. The condition is still potentially dangerous because bilirubin can accumulate in the basal ganglia of the brain, where it can cause permanent brain damage. Such brain damage, better known as kernicterus, can manifest as cerebral palsy, deafness, language difficulty, or in the worst cases, be fatal.

This study will be conducted at a hospital in Botswana, where the study aim to collect data from newborns with a broad range of bilirubin levels and high melanin content.

The investigators hypothesize that the Picterus JP will offer bilirubin level estimates that are highly correlated to bilirubin levels measured in blood samples in a population in Botswana. Following our hypothesis, the short-term goal for this project is to demonstrate that this screening method can be used to identify children with severe neonatal jaundice independent of skin color. Thus, providing a cheaper, patient-friendly, and more readily available means of neonatal jaundice detection.

The study will be a diagnostic accuracy cross-sectional study with quantitative methods of data collection.

The study population will comprise 150 newborns from the Neonatal Unit and the postnatal ward at Princess Marina Hospital, a number determined by a sample size calculation based on standard errors of the 95% limit agreement, as described by Bland and Alman.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
24 Hours 至 14 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Gestational age > 37 weeks
  • Birth weight > 2000 g and < 4500 g
  • Age > 24 hours and < 14 days
  • Infants requiring a blood sample for clinically suspected jaundice or other screening

排除标准

  • Infants transferred to the pediatric ward for advanced treatment
  • Infants with a skin rash or other disease that affects the skin where measurements are performed
  • Infants that receive or have received phototherapy in the last 24 hours
  • Infants with an inborn disease

结局指标

主要结局

Total serum bilirubin

时间窗: Must be performed within 1 hour of measurement with smartphone app and transcutaneous bilirubinometer

Total serum bilirubin determined by a blood sample

Picterus app estimate

时间窗: Must be performed within 1 hour of blood sample

Estimate of total serum bilirubin in the blood by a smartphone app

次要结局

  • Transcutaneous bilirubin(Must be performed within 1 hour of blood sample)

研究者

发起方
Hillerod Hospital, Denmark
申办方类型
Other
责任方
Principal Investigator
主要研究者

Julie Zimmer

Principal investigator

Hillerod Hospital, Denmark

研究点 (1)

Loading locations...

相似试验